These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 12767053)

  • 1. Modulation of metabolic control by angiotensin converting enzyme (ACE) inhibition.
    Henriksen EJ; Jacob S
    J Cell Physiol; 2003 Jul; 196(1):171-9. PubMed ID: 12767053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
    Henriksen EJ; Prasannarong M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme in skeletal muscle: sentinel of blood pressure control and glucose homeostasis.
    Dietze GJ; Henriksen EJ
    J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):75-88. PubMed ID: 18584583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress--mediated alterations in glucose dynamics in a genetic animal model of type II diabetes.
    Bitar MS; Al-Saleh E; Al-Mulla F
    Life Sci; 2005 Sep; 77(20):2552-73. PubMed ID: 15936776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of improving effect of losartan on insulin sensitivity of non-insulin-dependent diabetes mellitus rats.
    Wu Y; Ouyang JP; Zhou YF; Wu K; Zhao DH; Wen CY
    Sheng Li Xue Bao; 2004 Aug; 56(4):539-49. PubMed ID: 15322693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic effects of ACE inhibitors.
    Berne C
    J Intern Med Suppl; 1991; 735():119-25. PubMed ID: 2043220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
    Clerk LH; Vincent MA; Barrett EJ; Lankford MF; Lindner JR
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1804-9. PubMed ID: 17911341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Possible participation of angiotensin-converting enzyme and leukocyte elastase in the pathogenesis of insulin-independent diabetes mellitus].
    Dotsenko VL; Demidova TIu; Neshkova EA; Ametov AS; Iarovaia GA
    Vopr Med Khim; 1998; 44(2):203-12. PubMed ID: 9634724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells.
    Kohlstedt K; Brandes RP; Müller-Esterl W; Busse R; Fleming I
    Circ Res; 2004 Jan; 94(1):60-7. PubMed ID: 14615289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme (ACE) inhibitors modulate cellular retinol-binding protein 1 and adiponectin expression in adipocytes via the ACE-dependent signaling cascade.
    Kohlstedt K; Gershome C; Trouvain C; Hofmann WK; Fichtlscherer S; Fleming I
    Mol Pharmacol; 2009 Mar; 75(3):685-92. PubMed ID: 19114589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WY-14643 and 9- cis-retinoic acid induce IRS-2/PI 3-kinase signalling pathway and increase glucose transport in human skeletal muscle cells: differential effect in myotubes from healthy subjects and Type 2 diabetic patients.
    Bouzakri K; Roques M; Debard C; Berbe V; Rieusset J; Laville M; Vidal H
    Diabetologia; 2004 Jul; 47(7):1314-23. PubMed ID: 15292987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transport activity in insulin-resistant rat muscle. Effects of angiotensin-converting enzyme inhibitors and bradykinin antagonism.
    Henriksen EJ; Jacob S; Augustin HJ; Dietze GJ
    Diabetes; 1996 Jan; 45 Suppl 1():S125-8. PubMed ID: 8529793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway.
    Wong V; Szeto L; Uffelman K; Fantus IG; Lewis GF
    J Endocrinol; 2006 Aug; 190(2):441-50. PubMed ID: 16899577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic selective glycogen synthase kinase-3 inhibition enhances glucose disposal and muscle insulin action in prediabetic obese Zucker rats.
    Dokken BB; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E207-13. PubMed ID: 16478771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin and the renin-angiotensin-aldosterone system: influence of ACE inhibition.
    Ferrannini E; Seghieri G; Muscelli E
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S61-9. PubMed ID: 7700069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
    Rouyer O; Zoll J; Daussin F; Damgé C; Helms P; Talha S; Rasseneur L; Piquard F; Geny B
    Exp Physiol; 2007 Nov; 92(6):1047-56. PubMed ID: 17675412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinins, receptors, kininases and inhibitors--where did they lead us?
    Erdös EG; Marcic BM
    Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the cardiovascular effects of angiotensin-converting enzyme (ACE) I involve ACE-independent mechanisms? new insights from proline-rich peptides of Bothrops jararaca.
    Ianzer D; Santos RA; Etelvino GM; Xavier CH; de Almeida Santos J; Mendes EP; Machado LT; Prezoto BC; Dive V; de Camargo AC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):795-805. PubMed ID: 17475904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.